<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/1999/REC-html401-19991224/loose.dtd">
<html><head><title>Details for gene set ANTIVIRAL AND ANTI INFLAMMATORY EFFECTS OF NRF2 ON SARS COV 2 PATHWAY%WIKIPATHWAYS_20250210%WP5113%HOMO SAPIENS[GSEA]</title><link href='xtools.css' rel='stylesheet'><link href='https://www.gsea-msigdb.org/gsea/images/icon_16x16.png' rel='shortcut icon'></head><body><div class='keyValTable'><table cols='2' border='0'><th class='keyValTable'></th><th class='keyValTable'></th><tr><td>Dataset</td><td>ranked_genes_2</td></tr><tr><td>Phenotype</td><td>NoPhenotypeAvailable</td></tr><tr><td>Upregulated in class</td><td>na_pos</td></tr><tr><td>GeneSet</td><td>ANTIVIRAL AND ANTI INFLAMMATORY EFFECTS OF NRF2 ON SARS COV 2 PATHWAY%WIKIPATHWAYS_20250210%WP5113%HOMO SAPIENS</td></tr><tr><td>Enrichment Score (ES)</td><td>0.61675334</td></tr><tr><td>Normalized Enrichment Score (NES)</td><td>1.9606612</td></tr><tr><td>Nominal p-value</td><td>0.0028089888</td></tr><tr><td>FDR q-value</td><td>0.110345684</td></tr><tr><td>FWER p-Value</td><td>0.741</td></tr><caption class='table'>Table: GSEA Results Summary</caption></table></div><br><div class='image'><img name='enplot_ANTIVIRAL AND ANTI INFLAMMATORY EFFECTS OF NRF2 ON SARS COV 2 PATHWAY%WIKIPATHWAYS_20250210%WP5113%HOMO SAPIENS' src='enplot_ANTIVIRAL_AND_ANTI_INFLAMMATORY_EFFECTS_OF_NRF2_ON_SARS_COV_2_PATHWAY_WIKIPATHWAYS_20250210_W._199.png'><br><br><caption>Fig 1: Enrichment plot: ANTIVIRAL AND ANTI INFLAMMATORY EFFECTS OF NRF2 ON SARS COV 2 PATHWAY%WIKIPATHWAYS_20250210%WP5113%HOMO SAPIENS &nbsp&nbsp <br> Profile of the Running ES Score & Positions of GeneSet Members on the Rank Ordered List</caption></div><br><div class='richTable'><table cols='6' border='1'><th class='richTable'></th><th class='richTable'>SYMBOL</th><th class='richTable'>RANK IN GENE LIST</th><th class='richTable'>RANK METRIC SCORE</th><th class='richTable'>RUNNING ES</th><th class='richTable'>CORE ENRICHMENT</th><tr><td class='lessen'>1</td><td><a href='https://ensembl.org/Search/Results?q=HMOX1'>HMOX1</a></td><td>77</td><td>5.353</td><td>0.1371</td><td bgcolor='#CCFFCC'>Yes</td></tr><tr><td class='lessen'>2</td><td><a href='https://ensembl.org/Search/Results?q=NQO1'>NQO1</a></td><td>812</td><td>3.806</td><td>0.1819</td><td bgcolor='#CCFFCC'>Yes</td></tr><tr><td class='lessen'>3</td><td><a href='https://ensembl.org/Search/Results?q=IKBKG'>IKBKG</a></td><td>829</td><td>3.781</td><td>0.2817</td><td bgcolor='#CCFFCC'>Yes</td></tr><tr><td class='lessen'>4</td><td><a href='https://ensembl.org/Search/Results?q=KEAP1'>KEAP1</a></td><td>1053</td><td>3.505</td><td>0.3581</td><td bgcolor='#CCFFCC'>Yes</td></tr><tr><td class='lessen'>5</td><td><a href='https://ensembl.org/Search/Results?q=RXRA'>RXRA</a></td><td>1551</td><td>2.956</td><td>0.3985</td><td bgcolor='#CCFFCC'>Yes</td></tr><tr><td class='lessen'>6</td><td><a href='https://ensembl.org/Search/Results?q=GCLM'>GCLM</a></td><td>1643</td><td>2.863</td><td>0.4680</td><td bgcolor='#CCFFCC'>Yes</td></tr><tr><td class='lessen'>7</td><td><a href='https://ensembl.org/Search/Results?q=NFE2L2'>NFE2L2</a></td><td>1807</td><td>2.699</td><td>0.5275</td><td bgcolor='#CCFFCC'>Yes</td></tr><tr><td class='lessen'>8</td><td><a href='https://ensembl.org/Search/Results?q=GUCY1A2'>GUCY1A2</a></td><td>2454</td><td>2.133</td><td>0.5344</td><td bgcolor='#CCFFCC'>Yes</td></tr><tr><td class='lessen'>9</td><td><a href='https://ensembl.org/Search/Results?q=RELA'>RELA</a></td><td>2667</td><td>1.927</td><td>0.5694</td><td bgcolor='#CCFFCC'>Yes</td></tr><tr><td class='lessen'>10</td><td><a href='https://ensembl.org/Search/Results?q=NFKBIA'>NFKBIA</a></td><td>2893</td><td>1.722</td><td>0.5980</td><td bgcolor='#CCFFCC'>Yes</td></tr><tr><td class='lessen'>11</td><td><a href='https://ensembl.org/Search/Results?q=GCLC'>GCLC</a></td><td>3169</td><td>1.500</td><td>0.6168</td><td bgcolor='#CCFFCC'>Yes</td></tr><tr><td class='lessen'>12</td><td><a href='https://ensembl.org/Search/Results?q=NFKB1'>NFKB1</a></td><td>4416</td><td>0.621</td><td>0.5367</td><td>No</td></tr><tr><td class='lessen'>13</td><td><a href='https://ensembl.org/Search/Results?q=CCL2'>CCL2</a></td><td>5312</td><td>0.145</td><td>0.4711</td><td>No</td></tr><tr><td class='lessen'>14</td><td><a href='https://ensembl.org/Search/Results?q=PRKG2'>PRKG2</a></td><td>5619</td><td>0.032</td><td>0.4483</td><td>No</td></tr><tr><td class='lessen'>15</td><td><a href='https://ensembl.org/Search/Results?q=SLC7A11'>SLC7A11</a></td><td>6992</td><td>-0.578</td><td>0.3573</td><td>No</td></tr><tr><td class='lessen'>16</td><td><a href='https://ensembl.org/Search/Results?q=IRF3'>IRF3</a></td><td>7883</td><td>-1.151</td><td>0.3190</td><td>No</td></tr><tr><td class='lessen'>17</td><td><a href='https://ensembl.org/Search/Results?q=CHUK'>CHUK</a></td><td>9912</td><td>-2.644</td><td>0.2324</td><td>No</td></tr><caption class='table'>Table: GSEA details&nbsp<a href='ANTIVIRAL AND ANTI INFLAMMATORY EFFECTS OF NRF2 ON SARS COV 2 PATHWAY%WIKIPATHWAYS_20250210%WP5113%HOMO SAPIENS.tsv'>[plain text format]</a></caption></table></div><br><div class='image'><img name='gset_rnd_es_dist' src='gset_rnd_es_dist_200.png'><br><br><caption>Fig 2: ANTIVIRAL AND ANTI INFLAMMATORY EFFECTS OF NRF2 ON SARS COV 2 PATHWAY%WIKIPATHWAYS_20250210%WP5113%HOMO SAPIENS: Random ES distribution &nbsp&nbsp <br> Gene set null distribution of ES for <b>ANTIVIRAL AND ANTI INFLAMMATORY EFFECTS OF NRF2 ON SARS COV 2 PATHWAY%WIKIPATHWAYS_20250210%WP5113%HOMO SAPIENS</b></caption></div><br></body></html>